Renal Cell Carcinoma Clinical Trials

ReadTheTrial indexes 1 studies for Renal Cell Carcinoma. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Renal Cell Carcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
100%

Trial Status Breakdown

Trials for Renal Cell Carcinoma

A Phase 1 Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Allogeneic CRISPR-Cas9-Engineered T Cells (CTX130) in Subjects With Advanced, Relapsed or Refractory Renal Cell Carcinoma With Clear Cell Differentiation

NCT04438083 · TERMINATED · Phase 1

Frequently Asked Questions

What clinical trials are available for Renal Cell Carcinoma?

There are 1 clinical trials listed for Renal Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Renal Cell Carcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Renal Cell Carcinoma trials in?

Current Renal Cell Carcinoma trials are distributed across: Phase 1 (1).

Find More Trials